Compass Therapeutics, Inc. CMPX

Full chart Compare
Set alert

Price alert · CMPX

All alert types
0.77 USD +0.02 (+2.40%)

Nov 4, 2026, 12:01 PM EST

0.7541 Day range 0.7999
0.73 52-week range 6.88
YTD
-85.64%
1 year
-79.65%

Revenue & Expenses

Other Income → Expenses: $7.25MExpenses → Selling, General & Admin: $15.13MExpenses → Research & Development: $42.34MGross Profit → Expenses: $850.00KRevenue → Gross Profit: $850.00KNet Loss → Expenses: $49.38MOther Income$7.25MGross Profit$850.00KNet Loss$49.38MExpenses$57.48MSelling, General & Admin$15.13MResearch & Development$42.34MRevenue$850.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

CMPX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-72.84M-56.63M-50.36M-41.66M-81.88M
-66.49M-49.38M-42.49M-39.23M-82.18M
-0.42-0.36-0.33-0.37-1.31
CMPX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
31.21M44.05M24.23M34.95M144.51M
219.59M140.40M156.88M199.65M153.76M
22.80M15.17M8.34M18.01M13.68M
9.83M6.63M1.73M2.94M4.04M
196.79M125.23M148.54M181.64M140.08M
CMPX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-49.14M-44.85M-40.62M-34.13M-19.67M
-93.31M46.77M26.96M-151.20M-1.77M
129.61M17.34M2.94M75.76M118.61M
-25.00K-44.00K-30.00K-36.00K-1.45M
-12.84M19.25M-10.72M-109.57M97.17M